Lilly’s weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk

WASHINGTON — The U.S. Food and Drug Administration approved Eli Lilly’s weight-loss pill on April 1, setting up its next battle with rival Novo Nordisk for the millions of Americans seeking highly effective GLP-1 medicines.